A Marezine, Valoid, Nausicalm CEP of the European Pharmacopoeia monograph is often referred to as a Marezine, Valoid, Nausicalm Certificate of Suitability (COS). The purpose of a Marezine, Valoid, Nausicalm CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Marezine, Valoid, Nausicalm EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Marezine, Valoid, Nausicalm to their clients by showing that a Marezine, Valoid, Nausicalm CEP has been issued for it. The manufacturer submits a Marezine, Valoid, Nausicalm CEP (COS) as part of the market authorization procedure, and it takes on the role of a Marezine, Valoid, Nausicalm CEP holder for the record. Additionally, the data presented in the Marezine, Valoid, Nausicalm CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Marezine, Valoid, Nausicalm DMF.
A Marezine, Valoid, Nausicalm CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Marezine, Valoid, Nausicalm CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Marezine, Valoid, Nausicalm suppliers with CEP (COS) on PharmaCompass.